product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
AMPA Receptor (GluR 1) (D4N9V) Rabbit mAb
catalog :
13185
clonality :
monoclonal
host :
domestic rabbit
conjugate :
nonconjugated
clone name :
D4N9V
reactivity :
human, mouse, rat
application :
western blot, immunocytochemistry
citations: 5
Published Application/Species/Sample/DilutionReference
  • immunocytochemistry; mouse; 1:400; loading ...; fig 1i
  • western blot; mouse; 1:1000; loading ...; fig 1d
Rodriguez Ortiz C, Prieto G, Martini A, Forner S, Trujillo Estrada L, LaFerla F, et al. miR-181a negatively modulates synaptic plasticity in hippocampal cultures and its inhibition rescues memory deficits in a mouse model of Alzheimer's disease. Aging Cell. 2020;19:e13118 pubmed publisher
  • immunocytochemistry; rat; 1:100; loading ...; fig 3d
  • western blot; rat; 1:1000; loading ...; fig 2f
Ye J, Yin Y, Liu H, Fang L, Tao X, Wei L, et al. Tau inhibits PKA by nuclear proteasome-dependent PKAR2α elevation with suppressed CREB/GluA1 phosphorylation. Aging Cell. 2020;19:e13055 pubmed publisher
  • western blot; rat; 1:1000; loading ...; fig 7a
Qi X, Zhang K, Xu T, Yamaki V, Wei Z, Huang M, et al. Sex Differences in Long-Term Potentiation at Temporoammonic-CA1 Synapses: Potential Implications for Memory Consolidation. PLoS ONE. 2016;11:e0165891 pubmed publisher
  • western blot; mouse; 1:1000; loading ...; fig 1f, S10a
Roy A, Kundu M, Jana M, Mishra R, Yung Y, Luan C, et al. Identification and characterization of PPAR? ligands in the hippocampus. Nat Chem Biol. 2016;12:1075-1083 pubmed publisher
  • western blot; mouse; 1:500; fig 1
  • western blot; human; 1:500; fig 1
Maraschi A, Ciammola A, Folci A, Sassone F, Ronzitti G, Cappelletti G, et al. Parkin regulates kainate receptors by interacting with the GluK2 subunit. Nat Commun. 2014;5:5182 pubmed publisher
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.